Hyperprogressive Disease and Early Hypereosinophilia After Anti-PD-1 Treatment: A Case Report

Hyperprogressive disease (HPD) has been recently proposed as a new pattern of progression in patients treated with immune checkpoint inhibitors (ICIs). Until now, no biological marker has been found to predict this accelerated tumour growth. We describe the case of a 62-year-old women who experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Occhipinti, Mario, Falcone, Rosa, Onesti, Concetta Elisa, Marchetti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849760/
https://www.ncbi.nlm.nih.gov/pubmed/29536185
http://dx.doi.org/10.1007/s40800-018-0078-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849760/
https://www.ncbi.nlm.nih.gov/pubmed/29536185
http://dx.doi.org/10.1007/s40800-018-0078-z

Ejemplares similares